Tranexamic acid in hip and spine surgery for children with cerebral palsy — a PRISMA-compliant scoping review
Tranexamsäure in der Hüft- und Wirbelsäulenchirurgie bei Kindern mit Zerebralparese — PRISMA-konforme Scoping-Übersicht
Systematic Reviews · 27.12.2024 · 13 (1)
DOI: 10.1186/s13643-024-02734-7 ↗Auf einen Blick
Die Scoping-Übersicht kartiert die Evidenz zu Tranexamsäure bei Hüft- und Wirbelsäulenoperationen von Kindern mit Zerebralparese. Die berichtete Wirksamkeit war gemischt, Sicherheit wurde meist als gegeben beschrieben.
Fragestellung
Welche Evidenz liegt zu Tranexamsäure bei Hüft- und Wirbelsäulenoperationen bei Kindern mit Zerebralparese vor?
Methode
Prospektiv registrierte Scoping-Übersicht; Titel und Abstracts von 14.609 Einträgen gescreent; 52 Records plus 2 aus Grauer Literatur und Zitationssuche eingeschlossen.
Ergebnisse
52 Records eingeschlossen; 50,0 % Kohortenstudien, 76,9 % zur Wirbelsäulenchirurgie. Dosisangaben variierten stark; 35,2 % ohne Dosisangabe. Primäre Endpunkte waren Blutverlust und Transfusionsbedarf.
Einschränkungen
Heterogene Literatur; breite Einschlusskriterien; keine Evidenz zur postoperativen TXA-Gabe.
Schlussfolgerung der Autor:innen
Tranexamsäure wird insgesamt als sicher beschrieben, die Evidenz zur Wirksamkeit ist jedoch gemischt.
Kernaussagen
- 5 bis 100 mg/kg als Loading-Dosis; 1 bis 10 mg/kg/h als Infusion
- Primäre Endpunkte: Blutverlust und Transfusionsbedarf
- Keine Studien zur postoperativen Tranexamsäure-Gabe
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Scoping Review in der Zeitschrift Systematic Reviews, online erschienen am 27.12.2024. Verfasst von Daniel Gould und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, The Royal Children's Hospital, University of Melbourne, 50 Flemington Road, Parkville, VIC, 3052, Australia. daniel.gould@…. Hauptthemen laut MEDLINE: Tranexamic Acid, Cerebral Palsy, Antifibrinolytic Agents, Blood Loss, Surgical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Many children with cerebral palsy (CP) are frail and require major hip and/or spine surgeries associated with substantial blood loss. Tranexamic acid (TXA) is commonly used to reduce blood loss, but there is uncertainty around the optimal dose and timing of administration. There have been reviews in sub-populations and specific dosing regimens, but a broad overview of the available literature is lacking. The aim of this review was to map available evidence on TXA in hip and spine surgery for children with CP. Given the heterogeneous literature, a prospectively registered scoping review was conducted. Eligibility criteria were broad. Three screeners were involved, with the senior author consulted when disagreements were not resolved through discussion. Titles and abstracts of 14,609 records were screened, with 52 records included. Two additional records were obtained from grey literature and citation searching. Cohort studies (50.0%) were the most common. Most records (76.9%) were on spine surgery. TXA dose varied widely. Loading doses range from 5 to 100 mg/kg and intraoperative infusions from 1 to 10 mg/kg/h. Dose was not reported in 35.2% of records. Primary outcome measures included blood loss and transfusion requirements. TXA was generally reported to be safe. None of the included records reported postoperative TXA administration. While TXA is generally considered safe, there was mixed evidence on efficacy. Much of the evidence was drawn from studies in which TXA was used in patients at higher risk of bleeding or with reduced physiological reserve. There was no evidence for TXA being used postoperatively, when a large proportion of transfusions occur.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, The Royal Children's Hospital, University of Melbourne, 50 Flemington Road, Parkville, VIC, 3052, Australia. daniel.gould@unimelb.edu.au.
- Monash Medical Centre, 246 Clayton Rd, Clayton VIC 3168, Melbourne, Australia.
- Alfred Health, 55 Commercial Rd, Melbourne VIC 3004, Australia.
- Department of Anaesthesia and Pain Management, Royal Children's Hospital, 50 Flemington Road, Parkville VIC 3052, Melbourne, Australia.
- Department of Paediatrics, The Royal Children's Hospital, University of Melbourne, 50 Flemington Road, Parkville, VIC, 3052, Australia.
- Department of Orthopaedics, The Royal Children's Hospital, Melbourne, 3052, Australia.
ORCID-Profile: Daniel Gould
Zitieren
APA
Gould, D., Cui, H., Ma, N., Chalkiadis, G., Davidson, A., Graham, K., & Rutz, E. (2024). Tranexamic acid in hip and spine surgery for children with cerebral palsy — a PRISMA-compliant scoping review. Systematic Reviews, 13(1). https://doi.org/10.1186/s13643-024-02734-7
Vancouver
Gould D, Cui H, Ma N, Chalkiadis G, Davidson A, Graham K, et al. Tranexamic acid in hip and spine surgery for children with cerebral palsy — a PRISMA-compliant scoping review. Systematic Reviews. 2024;13(1). doi:10.1186/s13643-024-02734-7
BibTeX
@article{Gould2024,
author = {Gould, Daniel and Cui, Haoze and Ma, Norine and Chalkiadis, George and Davidson, Andrew and Graham, Kerr and Rutz, Erich},
title = {Tranexamic acid in hip and spine surgery for children with cerebral palsy — a PRISMA-compliant scoping review},
journal = {Systematic Reviews},
year = {2024},
volume = {13},
number = {1},
doi = {10.1186/s13643-024-02734-7}
}
EUVIMED